Novo Nordisk As Stock Price History
NVO Stock | USD 115.12 0.04 0.03% |
Below is the normalized historical share price chart for Novo Nordisk AS extending back to April 30, 1981. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Novo Nordisk stands at 115.12, as last reported on the 7th of October, with the highest price reaching 115.16 and the lowest price hitting 113.79 during the day.
If you're considering investing in Novo Stock, it is important to understand the factors that can impact its price. Novo Nordisk AS has Sharpe Ratio of -0.11, which conveys that the firm had a -0.11% return per unit of risk over the last 3 months. Novo Nordisk exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please verify Novo Nordisk's Standard Deviation of 2.44, risk adjusted performance of (0.08), and Mean Deviation of 1.8 to check out the risk estimate we provide.
At this time, Novo Nordisk's Total Stockholder Equity is very stable compared to the past year. As of the 7th of October 2024, Liabilities And Stockholders Equity is likely to grow to about 330.2 B, while Common Stock Shares Outstanding is likely to drop about 3.7 B. . As of the 7th of October 2024, Price To Sales Ratio is likely to grow to 14.16. Also, Price Earnings Ratio is likely to grow to 39.29. Novo Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 4th of January 1982 | 200 Day MA 127.1522 | 50 Day MA 130.3418 | Beta 0.148 |
Novo |
Sharpe Ratio = -0.1124
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns | NVO |
Estimated Market Risk
2.44 actual daily | 21 79% of assets are more volatile |
Expected Return
-0.27 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
-0.11 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Novo Nordisk is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Novo Nordisk by adding Novo Nordisk to a well-diversified portfolio.
Price Book 30.7533 | Enterprise Value Ebitda 25.8242 | Price Sales 1.9859 | Shares Float 3.2 B | Dividend Share 9.9 |
Novo Nordisk Stock Price History Chart
There are several ways to analyze Novo Stock price data. The simplest method is using a basic Novo candlestick price chart, which shows Novo Nordisk price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest Price | July 12, 2024 | 141.55 |
Lowest Price | October 3, 2024 | 115.08 |
Novo Nordisk October 7, 2024 Stock Price Synopsis
Various analyses of Novo Nordisk's daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Novo Stock. It can be used to describe the percentage change in the price of Novo Nordisk from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Novo Stock.Novo Nordisk Price Rate Of Daily Change | 1.00 | |
Novo Nordisk Price Action Indicator | 0.67 | |
Novo Nordisk Price Daily Balance Of Power | 0.03 |
Novo Nordisk October 7, 2024 Stock Price Analysis
Novo Stock Price History Data
The price series of Novo Nordisk for the period between Tue, Jul 9, 2024 and Mon, Oct 7, 2024 has a statistical range of 27.45 with a coefficient of variation of 5.11. The daily prices for the period are spread out with arithmetic mean of 131.76. The median price for the last 90 days is 132.78. The company underwent 2:1 stock split on 20th of September 2023. Novo Nordisk AS issued dividends to stockholders on 2024-08-16.Open | High | Low | Close | Volume | ||
10/07/2024 | 114.24 | 115.16 | 113.79 | 115.12 | ||
10/04/2024 | 114.24 | 115.16 | 113.79 | 115.12 | 6,177,024 | |
10/03/2024 | 116.24 | 116.33 | 115.03 | 115.08 | 4,312,627 | |
10/02/2024 | 116.68 | 116.79 | 115.40 | 116.48 | 5,905,151 | |
10/01/2024 | 118.79 | 118.92 | 117.32 | 118.01 | 3,555,454 | |
09/30/2024 | 117.59 | 119.12 | 117.49 | 119.07 | 6,472,823 | |
09/27/2024 | 120.55 | 121.34 | 119.15 | 120.76 | 9,475,677 | |
09/26/2024 | 125.60 | 125.60 | 123.98 | 124.30 | 4,366,183 | |
09/25/2024 | 127.37 | 127.61 | 126.41 | 126.95 | 2,934,434 | |
09/24/2024 | 124.32 | 126.66 | 123.77 | 125.44 | 4,787,409 | |
09/23/2024 | 124.00 | 125.27 | 122.94 | 123.70 | 6,519,081 | |
09/20/2024 | 129.10 | 129.48 | 126.13 | 127.51 | 9,241,631 | |
09/19/2024 | 134.66 | 135.18 | 133.63 | 134.88 | 2,548,708 | |
09/18/2024 | 132.83 | 133.27 | 131.30 | 132.06 | 2,778,137 | |
09/17/2024 | 133.60 | 135.16 | 131.80 | 132.00 | 3,316,166 | |
09/16/2024 | 138.06 | 138.22 | 136.77 | 136.90 | 1,639,188 | |
09/13/2024 | 136.86 | 137.89 | 136.37 | 137.00 | 2,309,135 | |
09/12/2024 | 135.24 | 136.97 | 134.66 | 136.66 | 2,003,103 | |
09/11/2024 | 133.14 | 135.82 | 130.98 | 135.23 | 3,888,212 | |
09/10/2024 | 129.23 | 130.12 | 128.42 | 129.78 | 2,140,370 | |
09/09/2024 | 132.03 | 132.94 | 130.91 | 131.91 | 1,766,414 | |
09/06/2024 | 133.76 | 134.15 | 130.57 | 131.14 | 2,589,793 | |
09/05/2024 | 132.01 | 132.66 | 130.53 | 130.89 | 2,631,525 | |
09/04/2024 | 134.04 | 134.91 | 133.63 | 134.53 | 1,810,074 | |
09/03/2024 | 138.56 | 138.58 | 135.83 | 136.26 | 2,248,465 | |
08/30/2024 | 138.21 | 139.74 | 137.85 | 139.16 | 2,609,598 | |
08/29/2024 | 136.47 | 137.88 | 135.74 | 137.52 | 2,595,858 | |
08/28/2024 | 134.66 | 135.17 | 134.10 | 134.48 | 2,765,400 | |
08/27/2024 | 133.91 | 135.50 | 133.77 | 135.18 | 1,978,574 | |
08/26/2024 | 135.24 | 135.72 | 134.62 | 135.30 | 1,780,516 | |
08/23/2024 | 136.57 | 137.15 | 135.92 | 136.97 | 2,112,073 | |
08/22/2024 | 137.33 | 138.49 | 136.11 | 136.88 | 2,723,020 | |
08/21/2024 | 135.35 | 135.57 | 133.38 | 134.96 | 2,410,283 | |
08/20/2024 | 135.19 | 136.34 | 134.54 | 135.81 | 2,106,412 | |
08/19/2024 | 135.07 | 136.13 | 134.95 | 135.25 | 1,681,419 | |
08/16/2024 | 135.40 | 135.67 | 134.66 | 134.89 | 2,110,848 | |
08/15/2024 | 136.10 | 137.17 | 135.04 | 137.05 | 2,916,109 | |
08/14/2024 | 132.20 | 134.34 | 131.74 | 133.91 | 1,967,949 | |
08/13/2024 | 131.07 | 133.75 | 131.07 | 133.07 | 3,343,413 | |
08/12/2024 | 131.08 | 131.53 | 129.06 | 129.40 | 3,602,690 | |
08/09/2024 | 129.95 | 134.15 | 129.72 | 132.97 | 7,503,650 | |
08/08/2024 | 125.42 | 127.86 | 122.75 | 127.69 | 10,281,320 | |
08/07/2024 | 122.23 | 123.16 | 118.35 | 118.78 | 13,899,860 | |
08/06/2024 | 128.27 | 130.78 | 127.80 | 129.63 | 6,994,281 | |
08/05/2024 | 123.42 | 126.95 | 122.27 | 125.53 | 5,888,813 | |
08/02/2024 | 129.30 | 129.65 | 126.38 | 127.01 | 4,774,033 | |
08/01/2024 | 131.55 | 133.84 | 130.61 | 131.96 | 3,669,049 | |
07/31/2024 | 132.25 | 132.39 | 131.15 | 132.13 | 3,580,362 | |
07/30/2024 | 130.61 | 131.18 | 127.11 | 128.74 | 4,388,093 | |
07/29/2024 | 127.53 | 129.05 | 126.91 | 127.57 | 3,093,983 | |
07/26/2024 | 126.38 | 127.78 | 125.89 | 126.25 | 3,179,137 | |
07/25/2024 | 128.62 | 129.50 | 125.88 | 127.38 | 5,326,126 | |
07/24/2024 | 132.01 | 132.40 | 130.43 | 131.11 | 2,663,352 | |
07/23/2024 | 133.06 | 134.17 | 132.52 | 132.78 | 2,383,245 | |
07/22/2024 | 131.51 | 132.76 | 131.36 | 132.68 | 3,720,422 | |
07/19/2024 | 132.12 | 133.00 | 130.81 | 131.05 | 4,319,544 | |
07/18/2024 | 134.43 | 134.46 | 126.35 | 129.50 | 9,758,249 | |
07/17/2024 | 135.90 | 136.11 | 133.92 | 134.91 | 6,307,150 | |
07/16/2024 | 141.47 | 141.70 | 140.08 | 140.34 | 2,221,103 | |
07/15/2024 | 142.72 | 142.96 | 140.54 | 140.86 | 2,434,117 | |
07/12/2024 | 141.22 | 142.96 | 141.10 | 141.55 | 2,877,642 |
About Novo Nordisk Stock history
Novo Nordisk investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Novo is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Novo Nordisk AS will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Novo Nordisk stock prices may prove useful in developing a viable investing in Novo Nordisk
Last Reported | Projected for Next Year | ||
Common Stock Shares Outstanding | 4.5 B | 3.7 B | |
Net Income Applicable To Common Shares | 63.9 B | 67 B |
Novo Nordisk Stock Technical Analysis
Novo Nordisk technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Premium Stories Now
Premium StoriesFollow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |
All Next | Launch Module |
Novo Nordisk Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Novo Nordisk's price direction in advance. Along with the technical and fundamental analysis of Novo Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Novo to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | (0.08) | |||
Jensen Alpha | (0.39) | |||
Total Risk Alpha | (0.58) | |||
Treynor Ratio | (0.21) |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Additional Information and Resources on Investing in Novo Stock
When determining whether Novo Nordisk AS offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Novo Nordisk's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Novo Nordisk As Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Novo Nordisk As Stock:Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Novo Nordisk AS. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Novo Nordisk. If investors know Novo will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Novo Nordisk listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.039 | Dividend Share 9.9 | Earnings Share 2.97 | Revenue Per Share 57.802 | Quarterly Revenue Growth 0.253 |
The market value of Novo Nordisk AS is measured differently than its book value, which is the value of Novo that is recorded on the company's balance sheet. Investors also form their own opinion of Novo Nordisk's value that differs from its market value or its book value, called intrinsic value, which is Novo Nordisk's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Novo Nordisk's market value can be influenced by many factors that don't directly affect Novo Nordisk's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Novo Nordisk's value and its price as these two are different measures arrived at by different means. Investors typically determine if Novo Nordisk is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Novo Nordisk's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.